
zzso is an important issue in zzso surgery, and about zzso of all blood products are zzso in this clinical setting zzso zzso practices, however, are highly variable among different hospitals and more than zzso of zzso blood zzso have been considered zzso Furthermore, both bleeding and zzso blood zzso are associated with increased zzso zzso and hospital zzso In the past decades, several attempts have been made to find a universal zzso agent to ensure zzso during and after zzso zzso Most drugs studied in this context have either failed to reduce bleeding and zzso requirements or were associated with severe adverse events, such as acute zzso failure or zzso events and, in some cases, increased zzso zzso an individualized zzso zzso therapy zzso zzso seems to be more appropriate to stop bleeding in this complex clinical zzso The use of zzso zzso zzso and zzso management zzso guided by zzso tests such as zzso in combination with zzso zzso function tests such as whole blood zzso zzso and based on zzso therapy with zzso and zzso complex concentrate have been associated with reduced zzso blood zzso requirements, reduced zzso of zzso and zzso adverse events, and improved outcomes in cardiac zzso This article reviews the current literature dealing with the management of zzso in zzso surgery based on zzso zzso and with specific zzso factor concentrates and its impact on zzso requirements and patients' zzso 

